MIP and ocular melanoma: These antibodies also reacted with homologous OM (Fig. 2B) and the engineered rT-Nm-MIP-OM (Fig. 2C), with similar titres observed (∼0.37–0.67 × 106, P > 0.05) with all the immunizing preparations tested against both OM preparations.